Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBD Life is a leading Mexican biopharmaceutical and consumer healthcare company dedicated to the development and commercialization of cannabis-derived therapeutic products. As a first mover in the Mexican market, the company was among the first to receive regulatory approval from COFEPRIS, securing 21 distinct product licenses for CBD-infused goods. CBD Life maintains an extensive distribution network reaching over 40,000 pharmacies and retail locations throughout Mexico, including major chains such as Farmacias del Ahorro and San Pablo. The company has established strategic international partnerships, including an API supply agreement with Clever Leaves and manufacturing collaborations with GL Brands, to produce pharmaceutical-grade cannabinoid treatments. Its portfolio includes well-known consumer brands like Mariguanol and Foria, spanning topical balms, supplements, and functional beverages. CBD Life is currently advancing its clinical-stage pipeline to target chronic pain and neurological conditions with medical-grade cannabis formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Life.